Search Results
PARP Inhibitors in Recurrent Ovarian Cancer
PARP Inhibitors in Recurrent Ovarian Cancer
Dr. Liu on PARP Inhibitors in Recurrent Ovarian Cancer
Dr. Konecny on the Indications for PARP Inhibitors in Recurrent Ovarian Cancer
Dr. Campos Discusses Differences Between PARP Inhibitors in Recurrent Ovarian Cancer
Recurrent Ovarian Cancer: Choosing a PARP Inhibitor
Ovarian Cancer: Recurrence After PARP Inhibition
PARP Inhibition’s Role in Recurrent Ovarian Cancer
PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023
Defining Rucaparib’s Value in Recurrent Ovarian Cancer
New PARP Inhibitor Drug Approved to Treat Women with Recurrent Ovarian Cancer
Dr. Crafton on the Impact of PARP Inhibitors in Recurrent Ovarian Cancer